Dietary inorganic nitrate : role in exercise physiology, cardiovascular and metabolic regulation by Larsen, Filip
 i 
 
From the Department of Physiology and Pharmacology  
Karolinska Institutet, Stockholm, Sweden 
 
DIETARY INORGANIC NITRATE: 
ROLE IN EXERCISE 
PHYSIOLOGY, 
CARDIOVASCULAR AND 
METABOLIC REGULATION 
Filip Larsen 
 
 
Stockholm 2011 
 
 
 
  
 
All previously published papers were reproduced with permission from the publisher. 
 
Published by Karolinska Institutet. Printed by Larserics Digital Print AB 
 
© Filip Larsen, 2011 
ISBN 978-91-7457-397-8
 1 
 
ABSTRACT 
 
Nitric oxide (NO) is a ubiquitous signaling molecule with a vast number of tasks in the 
body, including regulation of cardiovascular and metabolic function. A decreased 
bioavailability of NO is a central event in disorders such as hypertension and metabolic 
syndrome. NO is also important in the regulation of blood flow and metabolism during 
exercise. The production of NO has previously been thought to be under the exclusive 
control of the nitric oxide synthases (NOS) but this view is now being seriously 
challenged. Recent lines of research suggest the existence of an NO-synthase 
independent pathway in which the supposedly inert NO oxidation products nitrate 
(NO3
-
) and nitrite (NO2
-
) can be reduced back to NO in blood and tissues. An important 
additional source of nitrate is our everyday diet and certain vegetables are particularly 
rich in this anion. In this thesis the possibility that dietary derived nitrate is metabolized 
in vivo to form reactive nitrogen oxides with NO-like bioactivity has been explored.  
It is shown that nitrate in amounts easily achieved via the diet, increases the systemic 
levels of nitrite and reduces blood pressure in healthy humans. Moreover, nitrate 
reduces whole body oxygen cost during submaximal and maximal exercise; a 
surprising effect involving improvement in mitochondrial efficiency and reduced 
expression of specific mitochondrial proteins regulating proton conductance. 
Alterations in the mitochondrial affinity for oxygen can explain this reduction in both 
submaximal and maximal oxygen consumption and predicts basal metabolic rate in 
humans. Finally, in mice lacking endothelial NO synthase, dietary supplementation 
with nitrate could reverse several features of the metabolic syndrome that develop in 
these animals. These studies demonstrate that dietary nitrate can fuel a nitrate-nitrite-
NO pathway with important implications for cardiovascular and metabolic functions in 
health and disease.   
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LIST OF ABBREVIATIONS 
 
 
ADP  Adenosine di phosphate  
ANT  Adenylate nucleotide transporter 
ATP  Adenosine tri phosphate 
BMR  Basal metabolic rate 
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CS  Citrate Synthase    
EDRF  Endothelium-derived relaxing factor  
ETS  Electron transport system 
FCCP  Carbonyl cyanide 3-chlorophenylhydrazone        
HRmax  Maximum heart rate 
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mtDNA  Mitochondrial deoxyribonucleic acid 
nDNA  Nuclear deoxyribonucleic acid 
NO                                       Nitric oxide 
NOS  Nitric oxide synthase  
sGC  Soluble guanylyl cyclase            
cGMP  Cyclic guanosine monophosphate 
PGC-1α Peroxisome proliferator-activated receptor gamma      
coactivator 1-alpha       
PVDF  Polyvinylidene Fluoride                                                      
RCR/RCI  Respiratory control ratio/index 
RER  Respiratory exchange ratio  
ROS  Reactive oxygen species 
RNS  Reactive nitrogen species 
NRF  Nuclear respiratory factor 
TFAM  Transcription factor A, mitochondrial 
UCP-3  Uncoupling protein 3 
VO2  Volume of consumed oxygen  
VCO2  Volume of exhaled carbon dioxide 
VO2max  Maximal oxygen consumption 
P50mito  Oxygen tension were mitochondrial respiration is    
  half-maximal 
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INTRODUCTION 
 
Physiology of nitric oxide 
In a seminal paper published in 1980 Furchgott and Zawadzki showed that blood vessels 
release a vasodilating substance from the endothelium in response to a wide range of 
stimuli [1]. This compound was initially termed EDRF (endothelium-derived relaxing 
factor) and was subsequently identified to be nitric oxide (NO), a tiny free radical gas [2].  
In 1998 Robert Furchgott, Louis Ignarro and Ferid Murad were awarded the Nobel Prize in 
Physiology or Medicine for the discovery of endogenous NO production and its role as a 
signaling molecule in the cardiovascular system. NO is synthesized in the body by a family 
of enzymes known as the nitric oxide synthases (NOS). The NOSs catalyze the oxidation of 
L-arginine to L-citrulline and NO with oxygen as a co-substrate. These enzymes exist in 
three isoforms; neuronal (nNOS, NOS1), endothelial (eNOS, NOS3) and inducible (iNOS, 
NOS2).  
NO exerts a vast number of signaling and regulatory functions in the body. In the 
circulation it has vasodilatory and anti-aggregatory properties. Primarily it acts as a second 
messenger in vasodilation which occurs via activation of soluble guanylyl cyclase (sGC), 
with resulting formation of cyclic guanosine mono phosphate (cGMP). cGMP then 
activates intracellular protein kinases ultimately resulting in vascular smooth muscle 
relaxation. The importance of NO in physiological regulation of vascular tone in mammals 
was early shown by the immediate increase in blood pressure that follows administration of 
a NOS inhibitor [3]. NO also has a number of effects that are independent of cGMP, one of 
these being its ability to competitively inhibit cytochrome c oxidase (COX) [4-6] the 
terminal enzyme in the mitochondrial electron transport system (ETS). Indeed, when the 
endogenous NO synthesis is blocked, blood pressure and tissue oxygen consumption 
increases [7]. Another proposed cGMP-independent function of NO and its reaction 
products is to facilitate reversible S-nitrosation of critical thiols in proteins, thereby 
regulating their function [8]. Moreover, the killing of bacteria, viruses, fungi and tumor 
cells by NO and its reaction products occurs mostly via cGMP–independent mechanisms 
[9]. 
 
For almost a century, nitroglycerin and other so called “organic nitrates” have been 
harnessed therapeutically against angina pectoris and high blood pressure [10]. In studies 
predating the discovery of endogenous NO generation this agent was showed to dilate 
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coronary arteries via the release of NO [11]. Today clinical applications of NO research 
include inhalation of NO to newborn babies with persistent pulmonary hypertension [12] 
and the use of exhaled NO as a marker of airway inflammation in asthmatics [13].  
 
Production and consumption of NO 
The levels of NO in the tissues are tightly regulated and determined by the balance between 
its production and consumption. The Km values for oxygen (the oxygen concentration were 
NO production is half-maximal) is around 20 µM for eNOS, 130 µM for iNOS and 350 
µM for nNOS [14] which is generally higher than the normal oxygen tension in the tissue 
that ranges from as low as 3 µM in contracting muscles [15] up to 60 µM [16] in some 
tissues under resting conditions. This means that the formation of NO from the enzymatic 
pathway is tightly regulated by the oxygen tension with more NO being generated at higher 
oxygen tensions.  
NO has a very short half-life in vivo, ranging from milliseconds to a few seconds 
depending on the surrounding chemical milieu and metabolic state of the tissue where it is 
produced. Once formed, NO is rapidly oxidized to nitrite (NO2
-), and eventually to nitrate 
(NO3
-) which is considered the terminal oxidation product. A classical reaction is the rapid 
and effective oxidation of NO following its reaction with oxygenated hemoglobin in blood 
thereby forming methemoglobin and nitrate. The rate of NO consumption is also dependent 
on oxygen tension with faster consumption at higher oxygen concentrations [17]. As 
mentioned above, one proposed physiological function of NO is to modulate mitochondrial 
respiration via COX inhibition which in turn will increase the oxygen tension in the tissue. 
In this manner, excessive NO production can thus mimic hypoxia but oxygen levels are in 
fact higher than normal, leading to pathological production of reactive nitrogen species 
(RNS) and possibly irreversible modifications of proteins [18]. The chemical 
characteristics of NO also make this gas very reactive towards other free radical species, in 
particular superoxide (O2
-) thereby forming peroxynitrite (ONOO-).  Peroxynitrite itself is 
also reactive and when protonated it can decompose to form nitrogen dioxide (NO2
.
) and 
hydroxyl radicals (OH
.
) – both potent oxidants with potentially pathological consequences. 
The cytotoxic properties of NO and its reaction products is also utilized by the white blood 
cells and other cells in response to infections with bacteria, virus or parasites. The ability to 
stimulate sGC,  inhibit mitochondrial respiration, the reactivity towards superoxide and the 
oxygen regulated half-life make NO very sensitive towards the metabolic condition and 
redox state of the tissue thus allowing it to act as a metabolic sensor and signaling 
molecule.  
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The nitrate-nitrite-NO pathway 
Ever since the discovery of endogenous NO formation the anions nitrite and nitrate have 
been considered inert oxidation products and have merely been utilized by researchers as 
markers of NOS activity. However, recent lines of research have seriously challenged this 
view and evidence for a reverse pathway in which nitrate and nitrite are reduced back to 
NO is now emerging. The bioactivation of nitrate to NO involves a peculiar enterosalivary 
pathway. In humans and other mammals circulating nitrate originates from endogenous and 
dietary sources. This nitrate is actively absorbed by the salivary glands and excreted in 
saliva which has more than 10-fold higher nitrate levels than blood [19].  In the oral cavity 
parts of the nitrate is reduced to nitrite by symbiotic bacteria residing on the back of the 
tongue [20]. These facultative anaerobic bacteria respire by utilizing nitrate as a terminal 
electron acceptor. The bacterial conversion of nitrate to nitrite results in salivary nitrite 
levels of around 50-250 µM, i.e. thousand-fold higher than in plasma (50-250 nM). In the 
acidic gastric milieu a non-enzymatic reduction of salivary nitrite to NO occurs after 
protonation of the nitrite anion. In fact, this is the site where NOS-independent NO 
generation was first discovered [21-22]. Not all nitrite entering the stomach is reduced to 
NO as described above but much is actually absorbed intact into the blood stream as shown 
by an increase in plasma nitrite after oral nitrate intake [19, 23]. More than 1 liter of saliva 
is produced and swallowed each day and this pathway therefore constitutes a large part of 
the nitrite delivered to the circulation.  
 
 Plasma nitrate Plasma nitrite  Saliva nitrate Saliva nitrite 
Fasting  30 ± 4  0.123 ± 0.019  190 ± 30  100 ± 21  
 
Nitrate intake  432 ± 44  0.229 ± 0.046  8200 ± 1000  700 ± 150  
Table 1) Concentrations (μM) of nitrate and nitrite in plasma and saliva at fasting 
conditions and 30 minutes after nitrate intake (10 mg kg
-1
). Adopted from [19].  
 
Interestingly, during the past decade it has become clear that a number of enzymatic 
pathways exist in blood and tissues for the further one-electron reduction of nitrite to NO.  
These include deoxyhemoglobin in blood and also tissue proteins including 
deoxymyoglobin [24], neuroglobin [25], cytochrome c oxidase [26], xanthine 
oxidoreductase [27], aldehyde oxidase [28], and even NOS itself [27]. In addition, acidic 
non-enzymatic nitrite reduction, similar to that in the stomach, may also occur systemically 
and this reaction is greatly enhanced in the presence of reducing agents including vitamin C 
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and polyphenols [29]. In the circulation the nitrite reductase capacity of deoxyhemoglobin 
has been proposed as an allosteric-dependent and hypoxia sensitive regulating mechanism 
of microcirculatory blood flow [30].  The nitrate-nitrite-NO pathway might seem redundant 
when there is already three isoforms of NOS with high capacity for NO production. 
However, a fundamental difference between the two pathways is that the NOSs are oxygen 
dependent [14]  while the nitrate-nitrite-NO pathway instead is greatly facilitated under 
hypoxia [31]. Thus, the latter pathway can be viewed as complementary to the NOS-
dependent pathway and can operate also under conditions with low tissue oxygen tension 
such as during exercise or tissue ischemia. In fact, the low physiological oxygen tensions 
during muscular contractions [15] and the relatively high Km of the NOSs for oxygen 
predicts that the enzymatic production of NO will be compromised during exercise. Under 
these conditions nitrite could possibly act as an alternative source of NO but it is important 
to bear in mind that besides NO, other potentially bioactive reactive nitrogen oxides might 
be formed from nitrite. These include nitros(yl)ation products and possibly also nitration 
products. Figure 1 is a schematic overview of the mammalian nitrate cycle and the 
biological targets for NO in the body. 
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Figure 1) Overview of the mammalian NO-cycle. Nitrate originating from both dietary 
and endogenous sources can be reduced to nitrite by oral bacteria or to a lesser extent 
xathine oxidoreductase (XOR). The further reduction from nitrite to NO is facilitated at 
low oxygen tension and can be catalyzed by several mechanisms. Once formed, NO can be 
oxidized back to nitrite by simple autooxidation or enzymatically via ceruloplasmin (Cp) 
and COX. Nitrite also reacts quickly with oxyhemoglobin forming nitrate and 
methemoglobin. NO can have direct biological effects or act as a second-messenger by 
stimulation of sGC (soluble guanylyl cyclase) to produce cGMP which vasodilates blood 
vessels. Further, NO can react with thiols (S-H) forming s-nitrosothiols (SNO) with 
important regulatory functions.  NO interaction with mitochondrial enzymes may result 
in superoxide formation and the reaction products peroxynitrite (ONOO
-
) and 
hydrogenperoxide (H2O2) can have signaling functions in the cell. 
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Dietary sources of nitrate and nitrite  
Besides the NOSs, the diet constitutes a major source of nitrate since it is found in a rather 
wide range of food sources. Vegetables are especially rich in nitrate  with green leafy 
vegetables such as spinach, lettuce and beetroot being the richest known sources containing 
up to 740 mg 100 g-1 fresh weight [32]. In contrast, most fruits are low in nitrate. 
Unfortunately, vegetables and fruits are often lumped together in epidemiological studies 
investigating the health effects of our diet. The levels of nitrite  are low in most vegetables 
but higher in cured meats such as bacon and ham where it is added as a preservative [32]. 
Under normal conditions the contribution of nitrate and nitrite from dietary vs endogenous 
sources is roughly equal but with a diet rich in vegetables this source becomes dominant 
[32]. Conversely, with massive activation of NOS such as in systemic inflammation, the 
contribution of nitrate from the NOS pathways increases dramatically [33].  Plasma levels 
of nitrate and nitrite can thus be influenced either by the activity of the NOSs or by 
adjusting the dietary intake of these two anions. Another possible means of manipulating 
plasma nitrite levels is to disrupt the enterosalivary pathway, either by using an 
antibacterial mouthwash or by spitting. Both these procedures have been used 
experimentally and they strongly attenuate the increase in nitrite seen after nitrate intake 
[19] and possibly also reduce basal nitrite levels. In aggregate, the systemic levels of nitrate 
and nitrite are highly dependent on our diet, and the fact that they can be considered as a 
major pool of potential NO bioactivity in the body raises the question concerning the 
nutritional value of theses anions. 
 
Is dietary nitrate carcinogenic? 
For more than half a century dietary nitrate has been considered a carcinogenic substance 
and a toxic residue in our food and water and the content is therefore strictly regulated in 
drinking water and fertilizers. The supposed carcinogenic mechanism is nitrite-dependent 
formation of nitrosating agents which can react with dietary amines, forming nitrosamines, 
substances with known carcinogenic properties [34]. However, despite extensive research 
no casual link between dietary nitrate intake and gastric cancer in humans has been found 
[35-36].  Another concern regarding nitrate in food and drinking water is the risk of 
methemoglobinemia in small children (blue baby syndrome). This can occur when nitrate is 
reduced to nitrite by bacteria in contaminated food and drinking water and toxic amounts of 
nitrite are ingested. However, extremely few cases have been reported during the last 
decades. Excessive nitrate intake can inhibit uptake of iodide by the thyroid gland. Indeed, 
high nitrate exposure in humans has been related to hypertrophy of the thyroid but without 
affecting iodine levels [37]. Recently, an association between nitrate levels in drinking 
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water and thyroid cancer was found in older women [38]. Some precautions are warranted 
when extrapolating nitrate levels in drinking water to cancer risks since nitrate in the water 
can be indicative of bad water quality in general. Further, only a small fraction of total daily 
nitrate exposure originates from water, the majority of nitrate (>80%) is derived from 
vegetables [9]. In general a diet rich in vegetables is associated with reduced risk of cancer 
[39-41]. Despite the apparent lack of evidence for a carcinogenic role of dietary-derived 
nitrate, research is still lacking regarding the long-term safety of nitrate salts, such as those 
used in this thesis. 
 
NO and the metabolic syndrome 
The metabolic syndrome is a cluster of medical conditions that increase the risk of 
developing diabetes and heart disease. The prevalence is rapidly increasing and around 
20% of the population in the United States is affected with increased blood pressure, 
glucose intolerance, dyslipidemia and central obesity as the diagnostic criteria [42].  
Interestingly, a genetic polymorphism that is associated with a defect in the endogenous 
production of NO has been proposed as a candidate for the underlying molecular 
mechanism behind the development of the metabolic syndrome [43-44]. In further support 
of the hypothesis that NO deficiency is important in the progression of this syndrome, it has 
been shown that mice lacking the eNOS gene (eNOS-/-) develop hypertension, 
hyperlipidemia and insulin resistance as they age [45]. NO is important in multiple 
functions that can explain why NO deficiency leads to the development of these symptoms. 
NO is directly implicated in skeletal muscle glucose uptake [46-47] and mediates insulin 
secretion from beta-cells [48]. Further, NO has been shown to trigger mitochondrial 
biogenesis [49] which is important to maintain the respiratory capacity in the tissue, a 
function that is often reduced in diabetes [50].  A change in diet is often suggested to 
patients with metabolic syndrome, diabetes or hypertension as a primary therapeutic 
intervention. A diet rich in fruit and vegetables, such as the Mediterranean diet, is 
considered beneficial under these circumstances [51]. Interestingly, this will provide high 
amounts of dietary nitrate and this fact triggered the studies on blood pressure and 
metabolic syndrome in this thesis. 
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Regulation of oxygen consumption  
A considerable part of this thesis is concentrated around the effects of dietary nitrate on 
various exercise parameters, in particular oxygen consumption. It therefore seems 
reasonable to discuss some basic exercise physiology. 
 
Oxygen consumption during submaximal exercise 
The oxygen consumption during submaximal work rates is dictated by the external work 
rate and the efficiency of energy transduction. During submaximal exercise on a cycle 
ergometer, oxygen uptake under steady-state conditions is an almost linear function of 
work rate and at any given level one finds very small inter- and intra-individual variations, 
regardless of training status [52], age or diet [53]. During such tests energy expenditure is 
most often measured by indirect calorimetry (oxygen consumption and carbon dioxide 
release), assuming that metabolic heat production is reflected by the amount of oxygen 
consumed. Gross efficiency (the ratio of mechanical work output to the metabolic energy 
input) during cycling is around 18-23 % in humans [54] with small inter-individual 
differences. The efficiency is dictated by the amount of slow-twitch, oxidative muscle 
fibers [55] and also the abundance of uncoupling protein 3 (UCP-3) expression [55], but 
physical training status does not seem to affect cycling efficiency [56]. On the 
mitochondrial level efficiency is often expressed as the amount of ATP produced per 
oxygen consumed on a molar basis (P/O ratio) [52, 56-57]. However, recent work indicates 
that mitochondrial P/O ratios in vivo are quite far below the estimated maximal 2.5 in vitro 
[55, 58-59] which implies that mitochondria operate below maximal efficiency.  Indeed, to 
obey the second law of thermodynamics all systems operating out of equilibrium must be 
inefficient/uncoupled to some degree.  The rather low gross efficiency could theoretically 
be explained by the degree of mitochondrial coupling but to date experimental evidence for 
a correlation between mitochondrial efficiency and muscular efficiency is lacking [55]. Part 
of the ATP produced in the mitochondria is used in the contraction of the muscular actin-
myosin filaments to generate mechanical work. However, the contractile efficiency is only 
around 60% [60] and thus constitutes yet another route of energy loss.   
 
Oxygen consumption during maximal exercise 
In contrast to oxygen uptake during submaximal work, the maximal oxygen consumption 
(VO2max) is not set by the external work rate but is limited by the subjects’ maximal 
ability to transport oxygen. The factor(s) that limit the maximal ability to extract oxygen 
from the air and its transport has been heavily disputed over (for review see [61]). Evidence 
now lean towards that cardiac output and central oxygen delivery is the major bottleneck in 
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the respiratory cascade, at least during work involving large muscle groups. This is 
illustrated by the change in VO2max when inducing anemia (decreased VO2max) or 
polycythemia (increased VO2max) to manipulate the oxygen carrying capacity of the blood 
[62]. Further, combined arm and leg exercise does not [63-64] or only marginally [65-67] 
increase VO2max compared to leg exercise alone, although the peripheral respiratory 
capacity has increased substantially. These and other human data [68] that show an excess 
in mitochondrial capacity predict that intracellular oxygen concentration will decrease to 
critically low levels during exercise. Indeed, oxygen tensions as low as 0.3-0.4 kPa (3-4 
µM) are found in working muscles [15, 69] rendering the ability of mitochondria to 
maintain respiration at these low oxygen tensions crucial to avoid severe oxygen limitation 
of respiration. The mitochondrial respiration rate (j’O2) is a hyperbolic function of oxygen 
tension: 
 
where pO2 is the average intracellular oxygen tension and p50mito is the oxygen tension were 
mitochondrial respiration proceeds at 50% of the oxygen saturated maximum rate. This 
equation explains the influence of p50mito on mitochondrial respiration rate.  A wide range 
of p50mito values can be found in the literature, from as low as 0.002 kPa [70] to 0.3 kPa 
[71]. If the p50mito was to be 0.002 kPa, oxygen availability would not exert any control 
over respiration. On the contrary, p50mito-values reaching 0.25 kPa would indicate that 
mitochondrial respiration would be half-inhibited already at normal physiological oxygen 
concentration and there would be little room for normal perturbations such as inhibition by 
NO or decreased respiration due to oxidative damage. Recently, advances in mitochondrial 
respiration research, through the introduction of High Resolution Respirometry (HRR), 
have allowed more precise measurements of p50mito. Using this technique, p50mito in rat 
heart and liver mitochondria is around 0.03-0.06 kPa [72]. Considering an oxygen tension 
of 0.4 kPa in working muscle, this means that mitochondrial respiration only reach 
approximately 90% of its maximum rate under these conditions. In the presence of 
physiological concentrations of NO the p50mito can be twice as high [73] due to the 
competitive inhibition of COX [74].  Together these results imply that even if the pumping 
capacity of the heart is the major determinant and limiting factor of VO2max, mitochondrial 
oxygen affinity (p50mito) can have a small but important regulatory role during maximal 
exercise.  
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Control of mitochondrial respiration by NO 
One of the primary regulatory effects of NO is its ability to competitively and reversibly 
bind to COX and thereby inhibiting mitochondrial respiration. This was first described by 
applying NO-donors to isolated mitochondria [4-6] and later NOS-inhibition was shown to 
be associated with increased oxygen consumption in resting dog muscles [75], a finding 
subsequently reproduced in several studies [76-78]. However,  the effects of NO-donors on 
whole body metabolism and oxygen consumption are more divergent, with studies showing 
inhibitory [79-80] or no effects [81]. Even though it has been unequivocally shown that NO 
can inhibit COX, this inhibition does not necessarily affect mitochondrial respiration since 
there is an overcapacity of COX relative to the flux of the electron transport system (ETS) 
[82-83]. NO can thus inhibit COX without reducing respiration up to the point where COX 
becomes rate limiting. The biological advantage of this apparent excess capacity of COX is 
at present unknown but there is evidence that a high COX activity is needed to keep 
mitochondrial oxygen affinity at a sufficiently high level (low p50mito) [83], while others 
argue that it is needed to avoid severe inhibition by NO under normal physiological 
conditions [82]. Given the excess of peripheral mitochondrial respiratory capacity over 
oxygen delivery from the heart and the excess of COX over other parts of the ETS, COX 
has to be severely inhibited before whole body oxygen consumption declines. In fact, even 
when isolated mitochondria are stimulated to full state 3 respiration only a fraction of the 
total COX capacity is utilized [84-85]. Still, studies that block endogenous NO-synthesis 
have repeatedly shown an increase in oxygen consumption both at the tissue and whole 
body level [75-78]. This indicates that physiological NO levels of around 20 nM [86] 
indeed have an impact on tissue oxygen consumption. An O2/NO ratio of around 500 has 
been proposed to attain half-inhibition of COX [73]. This would imply that at 10 µM 
oxygen, which is a physiological tissue oxygen tension, COX is already half-inhibited by 
NO. During increased metabolic demand oxygen tension can be as low as 3-4 µM [15, 69] 
and inhibition of NO is further increased. However, the excess of COX over other 
complexes in the ETS has been estimated to be eight-fold [87] allowing for severe 
inhibition of COX before mitochondrial respiration decreases.  
Another hypothesis on how nano molar concentrations of NO could influence oxygen 
consumption suggests that NO improves oxidative phosphorylation efficiency [88] 
indirectly via COX inhibition. COX transfer electrons to oxygen, simultaneously protons 
are pumped across the inner mitochondrial membrane. However, electrons can pass 
through the COX protein without pumping of protons [89-91], a phenomenon termed 
“proton slippage”. When COX is partially inhibited by NO and respiration slightly 
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decreases, there is evidence that ATP production is maintained to a larger degree than 
oxygen consumption, thereby increasing the P/O ratio. This effect has been attributed to a 
reduction in proton slippage [88] which is supported by the fact that inhibition of 
endogenous NO-production increases oxygen consumption without changes in ATP 
production [92].  
 
Mitochondrial efficiency and proton leak 
 As mentioned above there are several indications that mitochondria operate under less than 
maximal P/O ratios under physiological conditions. First, P/O ratios typically decrease as 
respiration decreases from state 3 (respiration with substrates and ADP) to state 4 
(respiration after ADP depletion) [55, 58, 93]. Given the excess mitochondrial respiratory 
capacity, physiological respiration is more close to state 4 than state 3, especially at a lower 
metabolic demand. Further, P/O ratios from in vivo measurements in humans indicate that 
some muscles exhibit  mild uncoupling [94].  In its broadest sense uncoupling refers to 
protons that are pumped over the inner mitochondrial membrane but are unrelated to ATP-
synthesis. The cause of uncoupling is relatively unknown but several putative mechanistic 
sites of proton leak have been proposed such as through the adenylate nucleotide 
transporter (ANT) [95-96], loss via metabolite transport through the UCPs [97] and also by 
unspecific permeability through the inner membrane [98].  Interestingly, UCP-1, the major 
metabolic uncoupler previously only found in rodents, has recently been found in small 
amounts also in humans [99] were it seems to be metabolically active [100] and can be 
important in thermogenesis and weight control. In humans, UCP-3 is found uniquely in 
skeletal muscle but its role in uncoupling is still debated. Another possible pathway of 
decreased coupling is by slip of the proton pumps as mentioned earlier, i.e. electrons can be 
transferred through a proton pumping complex without proton translocation. Slip seems to 
occur in all proton pumps at high membrane potential but is probably only physiologically 
significant in COX [101] . 
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AIMS 
The general objective of this thesis was to investigate metabolic and circulatory effects of 
inorganic nitrate in healthy humans as well as in rodents. New questions developed over 
time and the specific aims were: 
 
- To investigate the effect of dietary nitrate supplementation on resting blood 
pressure and blood pressure in response to exercise in healthy volunteers (study I 
and III). 
- To investigate the metabolic and circulatory response to exercise after 
supplementation with dietary nitrate in healthy subjects (study II and III). 
- To investigate if features of the metabolic syndrome that develops in eNOS-
deficient mice would be affected by dietary nitrate supplementation (Study IV). 
- To explore the effects of dietary nitrate on human skeletal muscle mitochondrial 
function in relation to whole body oxygen consumption during exercise (Study 
V). 
- To examine the relationship between mitochondrial oxygen affinity and different 
degrees of metabolic efficiency at rest and during exercise (Study VI).   
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MATERIALS AND METHODS 
 
A summary of the methods used in this project is presented below. For a more detailed 
description the reader is referred to the individual papers.  
 
Subjects 
In study I, II, III, V and VI healthy volunteers were enrolled. In the initial screening 
subjects were excluded if they were regular smokers, followed a vegetarian diet, were on 
chronic medication or had any other chronic illness or disability. The subjects in study II 
were well-trained young men, predominantly cyclists and triathletes. The subjects in study 
III, V and VI were healthy and active but not necessarily competitive athletes.  
 
Animals 
In study IV female eNOS-deficient, wild-type, and nNOS-deficient mice were obtained 
from Jackson Laboratories. Animals were randomly assigned to placebo and nitrate to 
ensure that each group had similar average age and weight. Sodium nitrate (85 mg L−1) was 
added to the drinking water during 8 to 10 weeks. For more detailed information on animal 
strains, housing and treatment see [102]. 
 
Nitrate supplementation and dietary restrictions 
For three days (two days in study III) before the tests, subjects were instructed to adhere to 
a diet with low nitrate content. This diet excluded all vegetables, cured meats, tea and 
alcohol-containing products which eliminate all food stuff with medium or high nitrate 
content but a small amount of nitrate intake still remains from drinking water and foods 
with lower nitrate content. In conjunction with these dietary restrictions, subjects were 
given 0.1 mmol kg-1 day-1 sodium nitrate or an equimolar amount sodium chloride 
(placebo) divided in three doses per day.   
 
Exercise protocols 
In study II an incremental exercise protocol was used with five submaximal workloads 
each lasting five minutes starting at approximately 45% and ending at 85% of VO2peak. 
There was no rest period between the work rates. After the submaximal test, a maximal 
exercise test was initiated starting at approximately 90% of VO2peak and increased every 
minute until exhaustion. In study III a maximal exercise test similar to the one in study II 
was used, but using combined arm and leg exercise, see study III for further details. In 
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study V and VI a single work rate was used were subjects cycled for approximately ten 
minutes to determine metabolic demand and circulatory parameters.  
 
Determination of VO2 and metabolic parameters  
Oxygen consumption, pulmonary ventilation and CO2 output (VCO2) were measured using 
an online metabolic gas analyser (AMIS 2001, Odense, Denmark in study II and III, Jaeger 
Oxycon Pro, Hoechberg, Germany in study V and VI).The AMIS 2001 gas analyzer was 
connected to a flow meter which the subjects breathed through via a mouthpiece and a 
plastic tube. The Jeager was used in conjunction with a face mask directly connected to a 
flow meter. In study III the Douglas bag technique was used together with the AMIS 2001 
as described [63]. The respiratory exchange ratio was calculated as the volume of exhaled 
carbon dioxide divided by the volume of oxygen uptake (VCO2/VO2). The basal metabolic 
rate (BMR) was measured after an overnight fast (at least 12 hours) and after at least 36 
hours of abstinence from physical training or other exhaustive activities. The subjects 
were allowed to rest on a bed in a quiet thermo neutral room for 30 minutes and then 
BMR was measured using the Jeager Oxycon Pro system described above. A plastic 
hood was placed over the head of the subject and ventilation was controlled by a 
computerized turbine and set between 25-50 L min
-1
. The lowest steady oxygen uptake 
recorded for approximately 10 minutes was used as the BMR.  
 
Measurements of blood pressure 
Blood pressure was measured in study I, II and III with a stethoscope and an inflatable 
sphygmomanometer, placed over the brachial artery. The first Korotkoff sound was used as 
systolic pressure while the fifth phase was interpreted as diastolic pressure. Blood pressure 
measurements were made with the subjects lying in the supine position. The resting blood 
pressure measurements were initiated after the subjects had been resting in a quiet room for 
at least 30 minutes.  
 
Calculation of energy expenditure and efficiency during cycling 
Energy expenditure was calculated from gas exchange data using the equation by Brouwer 
[103] in study II and V. The gross efficiency of energy conversion was calculated as the 
mechanical power output divided by the metabolic energy input.  Delta efficiency is a 
measure of the increase in metabolic energy input for a given increase in mechanical work 
output and was calculated as the slope of the linear regression line over the four lowest 
workloads according to Gaesser and Brooks [54]. Net efficiency is simply the mechanical 
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workload divided by (the basal metabolic rate subtracted from the total energy expenditure) 
[54].  
 
Muscle biopsies 
After anaesthesia (Lidocain without epinephrine) of the skin and muscle fascia, a small 
incision was made at the midsection of the Vastus Lateralis. Muscle biopsies were obtained 
using a chonchotome at a depth of 1-2 cm below the fascia. Biopsies were taken in a 
randomized fashion from the left or right leg when subjects had been treated with placebo 
or nitrate. Parts of the biopsies were immediately snap frozen in liquid nitrogen (-196°C) 
and stored in -80°C for later analysis of enzymatic activity or protein expression. The rest 
of the muscle tissue was placed in mitochondrial isolation medium (see below) and soon 
thereafter the isolation of mitochondria was initiated. 
 
Isolation of mitochondria 
The part of the muscle tissue designated for mitochondrial isolation was first weighed and 
then cut for five minutes in ice-cold isolation medium (Sucrose 100 mM, KCl 100 mM, 
Tris-HCl 50 mM, KH2PO4 1mM, EGTA 100 µM, BSA 0.1%), final pH was set to 7.4. 
After cutting, the homogenate was rinsed again in 1 ml isolation medium and the 
supernatant removed. 1 ml of isolation medium containing 0.2 mg ml-1 bacterial protease 
was added to the homogenate. The homogenate was incubated in this medium for a total of 
two minutes with 30 seconds of gentle shaking alternating with 30 seconds on ice. The 
homogenate was then transferred to a water-cooled glass jacket and homogenized with a 
hand held electrically driven drill (80 rpm) and immediately transferred to a falcon tube 
containing 3 ml isolation medium and subsequentially centrifuged at 700 g and 4° C for ten 
minutes. After removing the pellet the suspension was again centrifuged at 10000 g and 4° 
C. The pellet containing the mitochondria was carefully washed and then resuspended in 
0.65 ml isolation medium. After centrifugation at 7000 g for 5 minutes the pellet was 
dissolved in 0.6 µl preservation medium (EGTA 0.5 mM, MgCl2.6H2O 3 mM, K-
lactobionate 60 mM, Taurine 20 mM, KH2PO4 10 mM, HEPES 20 mM, Sucrose 110 mM, 
BSA 1 g/l Histidine 20 mM, Vitamin E succinate 20 μM, Glutathion 3 mM, Leupeptine 1 
μM, Glutamate 2 mM, Malate 2 mM, Mg-ATP 2 mM) per mg weight original tissue.  
 
Mitochondrial respiration 
All mitochondrial experiments presented in study V and VI were performed in a two-
channel respirometer (Oroboros Oxygraph, Paar, Graz, Austria) with the glass chamber 
volume set to 2 ml. PVDF magnetic stirrers and stoppers were used in conjugation with 
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rubber sealing to minimize oxygen back diffusion into the chamber [104]. Data were 
collected with one second intervals and averaged over 40 seconds. The medium in the 
respiration chamber was MiR05 containing (EGTA 0.5 mM, MgCl2.6H2O 3 mM, K-
lactobionate 60 mM, Taurine 20 mM, KH2P04 10 mM, HEPES 20 mM, Sucrose 110 mM, 
BSA 1 g/l).  All experiments were performed at 37° C; speed of the magnetic stirrers was 
set to 750 rpm.  Time constants for complete mixing in the chamber were calculated by 
briefly stopping and starting the stirrers. Oxygen consumption and zero-drift of the oxygen 
electrode were calculated using DatLab 2 and DatLab 4 software (Oroboros, Paar, Graaz, 
Austria). Diffusion of oxygen into the chamber was calculated as a linear function of 
oxygen tension in a separate background experiment using at least five different oxygen 
tensions. This background experiment were performed each time the membranes of the 
polarographic oxygen sensor were changed or when otherwise considered necessary.  The 
p50mito was calculated with DatLab 2 [105].  The term LEAK-respiration is used for the 
respiratory rate when mitochondria are exposed to saturating concentrations of respiratory 
substrates but in the absence of adenylates.  
When ADP is added in saturating amounts, respiration increases several-fold and is termed 
state 3 respiration. When all ADP is phosphorylated to ATP, respiration enters state 4. This 
state is driven by proton leakage and ATPase activity. The uncoupled state or “state 3u” is 
achieved by titration with FCCP. In human mitochondria an increase in respiration rate is 
observed when adding FCCP, up to an optimal concentration where after respiration is 
inhibited.   
 
P/O ratio 
In study V we measured the P/O ratio in isolated mitochondria at constant infusion of non-
saturating ADP-levels (modified from [58]) using a microdialysis pump (CMA 100, Solna, 
Sweden) through high-pressure hosing.  Before starting the ADP-infusion, 2 mM ATP was 
added to the medium. ADP was infused at a rate corresponding to approximately 50% of 
maximal state 3 respiration. Infusion started at an oxygen pressure of approximately 10 kPa 
and was determined before oxygen pressure reached 1 kPa. The effective P/O ratio was 
calculated as the rate of infused ADP divided by the oxygen consumed during steady state 
at the last minutes of infusion. Correction was made for the amount of oxygen added to the 
respiration medium by the infused ADP solution. ADP concentrations were verified by 
spectrophotometry. 
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Estimation of thermodynamic coupling 
Thermodynamic coupling (q) can be estimated using the equation: 
 
In mitochondrial respiration static head responds to state 4 respiration when the ANT 
protein is blocked by atractyloside. The uncoupled “state 3u” is achieved by a titration 
protocol with FCCP. At optimal concentration, the membrane potential is collapsed and the 
mechanism that couples oxidation to phosphorylation disappears. Therefore, in the 
uncoupled state, the “friction” of producing ATP vanishes and mitochondrial respiration 
reaches a maximum. The q-value is then a measure of the degree of thermodynamic 
coupling with values ranging from 0.88-0.97 in different rat organs [106]. 
 
Western blotting 
Freeze-dried muscle homogenates were dissolved in Laemmli sample buffer and 
denaturated by heating to 95º C for 10 minutes. Protein concentration of the 
homogenate was determined spectrophotometrically and 30 μg of protein was pipetted 
into each well on 12% polyacrylamide gels. The proteins were then separated by SDS-
PAGE for 60 minutes. The separated proteins were transferred to a PVDF membrane at 
10 V for 60 minutes and then blocked in TBS using 5% non-fat milk. Polyclonal 
antibodies against UCP3 (Chemicon AB3046), diluted 1: 500 and (ANT-1, Q-18, 
No.sc-9300, Santa Cruz) against ANT diluted 1: 200 were added to the solution and 
membranes were incubated over night. The membranes were then washed and again 
incubated with secondary antibody goat antirabbit (IgG-HRP, NO.sc-2030 Santa Cruz). 
The membrane was once again washed and a chemiluminescence detection marker was 
added. The optical density of the bands was quantified using Molecular Analyst 1.5 
(Bio-Rad). 
 
Rt-PCR 
In study IV gene expression of PGC-1α was measured in liver and muscle samples. In 
study V gene expression of COX IV, TFAM and PGC-1α was measured in human muscle 
biopsies. RNA was extracted from frozen tissues with a power homogenizer (KEBO-lab) 
and TRIzol reagent. One µg of total RNA was reverse transcribed using M-MLV reverse 
transcriptase. Relative expression levels of each gene were determined by real time PCR in 
a 7900 sequence-detection system (Applied Biosystems). In study V nuclear and 
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mitochondrial DNA was extracted with DNAesy Blood & Tissue Kit (QIAGEN) following 
the manufacturer’s instructions. The mitochondrial DNA and nuclear DNA quantification 
was carried out by multiplex real-time PCR, using the mtDNA qkit (Genemore Italy srl, 
Modena, Italy). The signal derived from the probes for mtDNA and nDNA was detected 
with FAM and TexasRed filters, respectively. An ABI PRISM 7500 Sequence Detector 
(Applied Biosystems) was used for the amplification and detection. 
 
IPGTT 
In study IV animals were subjected to an intraperitoneal glucose tolerance test (IPGTT). 
After an overnight fast, animals were weighed and a bolus of glucose (30% in H2O, 2 g 
kg−1) was injected into the intraperitoneal cavity. Blood samples were obtained from the tip 
of the tail at 0, 15, 30, 60, and 120 minutes post-injection. Blood glucose levels were 
determined with a hand-held glucose meter (Glucocard X-SENSOR; OneMed). 
 
Visceral fat, body weight and triglycerides 
 During the seven week treatment period mice were weighed once a week. At the 
termination experiment, all visceral abdominal adipose tissue was removed manually and 
weighed.  Triglycerides in blood were determined using a commercial kit (Cayman 
Chemical). 
 
Analysis of enzymatic activity 
Enzymatic activity of CS  was determined in homogenates from freeze-dried biopsies and 
isolated mitochondrial samples at 25° C as previously described [107]. COX activity was 
determined using Cytochrome C Oxidase assay kit from Sigma (CYTOCOX1) at 25° C 
according to the manufacturers' instructions. 
 
Chemiluminescence assay for nitrogen oxides 
Blood samples were collected in EDTA tubes and immediately centrifuged to avoid 
autooxidation of nitrite.  Analysis of nitrite, nitrate, and nitros(yl)ation products were 
determined by a chemiluminescence assay after reductive cleavage and quantification of 
the NO released into the gas phase [19]. In short, NO reacts with ozone (O3) which yields 
nitrogen dioxide (NO2). When NO2 in the electronically excited state (*NO2) returns to its 
ground state light is emitted and can be quantified by a photomultiplier. The samples were 
injected into a highly reducing solution in a micro reaction chamber. The condenser jacket 
temperature was controlled by a continuous flow of cold water while the temperature of the 
heating jacket was controlled by a continuous flow of warm water regulated by a constant-
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temperature circulating bath. A constant, controlled flow of nitrogen was used as the carrier 
gas of NO. The resulting NO signal was reported as the area under the curve. Calibration 
curves were obtained by standard solutions of nitrate or nitrite in ultrapure water. When 
analyzing nitrite the reducing solution consisted of potassium iodide (KI) 45 mM and 
iodine (I2) 10 mM, in acetic acid. The solution was kept at 56° C and continuously bubbled 
with nitrogen gas. Nitrite measurements were performed by injection of sample (50-100 μl) 
into the reducing solution. The amount of nitrite was quantified by simple subtraction of the 
peak area of sample aliquots pretreated with sulfanilamide from that of untreated aliquots. 
Nitrate was reduced to NO using a solution of vanadium (III) chloride in a saturated 
solution of hydrochloric acid at 95° C.  This reducing solution will also convert nitrite to 
NO, so the amount of nitrite measured first was subtracted from the nitrate concentration. 
To avoid foaming, the samples were deproteinized prior to analysis with three times as 
much cold ethanol as plasma.  
 
cGMP assay 
Plasma concentrations of cGMP were analyzed with a commercial available ELISA-kit 
(Bio-track EIA-System, Amersham). Samples were prepared according to the 
manufacturers’ instructions.  
 
Methodological precision 
The mitochondrial experiments in study V and VI were performed with High Resolution 
Respirometry, a method developed to improve the resolution of mitochondrial experiments. 
Relatively inert materials are chosen in the respiration chamber, stoppers and magnetic 
stirrers. Oxygen consumption of the electrode, diffusion of oxygen into the chamber, 
oxygen solubility in the medium and electrode drift are measured and corrected for. 
Temperature is controlled down to ±0.01° C.  These precautions increases the resolution of 
the measurements but simultaneously a reduction of noise might reveal larger variations 
between different experiments. In Table 2 data are presented on the variability between two 
experiments performed at identical assay conditions but in different chambers and at 
slightly different times after isolation but from the same mitochondrial suspension. 
Coefficients of variation (CV) is calculated from: 
CV=100 (SDn1-n2/Xn1n2) 
SDn1-n2 is the standard deviation of the difference of a number of duplicate experiments, 
Xn1n2 is the mean value of all those experiments. As a reference, in vivo data on 
submaximal and maximal oxygen consumption and heart rates are presented. These data 
are a sample of recent exercise tests (to be published) from our laboratory were subjects 
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perform identical submaximal and maximal exercise testing at two different days but under 
standardized laboratory conditions. 
 
 Number of observations CV 
LEAK respiration 25 24.8 % 
State 4 respiration 24 18.9 % 
State 3 respiration 33 7.8 % 
P/O ratio 23 10.6 % 
p50mito 24 12.5 % 
Submaximal VO2 cycling 20 3.6 % 
VO2max 40 2.9 % 
HRmax 40 1.3 % 
 
Table 2) Coefficients of variation between two separate observations of mitochondrial 
parameters measured in isolated mitochondria and whole-body physiological parameters 
measured during exercise. 
 
In the mitochondrial experiments the CV is apparently a function of respiration rate with 
the lower respiration rates in LEAK and state 4 yielding a higher signal to noise ratio and 
thus higher CV. The CV for VO2max and HRmax are very low and these can probably be 
considered two of the most stable parameters we can measure in biological systems. 
 
Statistics 
Overall results are expressed as mean ± S.E.M. In study II mean ± S.D was used. P-
values <0.05 was considered significant. Student’s paired t-test was used to compare 
single outcomes of placebo and nitrate supplementation in normally distributed data, 
otherwise Wilcoxon signed-rank test was used. Bonferroni correction was applied when 
multiple comparisons were made. Pearson r was used in correlation analysis. Data 
normality distribution was analyzed with D’Agostino and Pearson omnibus normality 
test. When multiple parameters were analysed two-way ANOVA with repeated measures 
were used. Dose-response experiments were analyzed with one-way ANOVA.  
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RESULTS AND COMMENTS 
 
Plasma levels of nitrate and nitrite in the human studies. 
After nitrate treatment, plasma concentrations of both nitrate and nitrite increased 
significantly in all studies (see Table 3). This finding confirms the effective absorption of 
nitrate and conversion to nitrite. 
 
 TREATMENT STUDY I 
(N=17) 
STUDY II 
(N=9) 
STUDY III 
(N=9) 
STUDY V 
(N=14) 
Nitrate 
(µM) 
 
Placebo 
 
 26±11  
 
27 ± 6.9 
 
17 ± 3.0  
 
27 ± 2.6  
Nitrate 
(µM) 
 
Nitrate 
 
178±51* 
 
182 ± 55*  
 
230 ± 31* 
 
169 ± 18*  
Nitrite 
(nM) 
 
Placebo 
 
 138±38 
 
124 ± 28  
 
61 ± 11  
 
35 ± 7 
Nitrite 
(nM) 
 
Nitrate 
 
219±105* 
 
226 ± 87*  
 
142 ± 35* 
 
163 ± 29* 
 
Table 3) Plasma concentrations of nitrate increased substantially after nitrate intake in all 
individuals. One hour after nitrate intake nitrite was elevated which confirms the salivary 
conversion of nitrate to nitrite. * p<0.05 versus placebo treatment. Values are mean ± 
S.E.M. 
 
Effects of inorganic nitrate on cGMP-levels 
We measured plasma levels of cGMP in study II, III, IV and V. In study IV we also 
measured cGMP in the tissue. The overall conclusion is that nitrate supplementation does 
not increase cGMP neither in blood nor in the tissue. If dietary nitrate does become reduced 
to NO, it is sound to expect that this NO would stimulate sGC to produce cGMP. However, 
the absence of effect on cGMP should not be interpreted as evidence that NO-production is 
not augmented by nitrate. Recently Kapil et al. found increased levels of cGMP in blood 
after administration of inorganic nitrate [108]. The sensitivity of the assay and 
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standardization of the blood sampling procedure is somewhat problematic. The CV of two 
measurements from the same subject on separate days is 72%, therefore small changes in 
cGMP are not readily detectable unless using a large number of subjects. Despite this, we 
cannot exclude that the nitrite ion itself or other nitrogen species exerts biological effects 
similar to NO or that the effects are mediated by cGMP-independent mechanisms.  
 
Effects of inorganic nitrate on blood pressure 
At the time of study I it was unknown if dietary nitrate could have any NO-like effects and 
nitrate was still considered to be virtually inert. If dietary nitrate is metabolised to 
appreciable amounts of NO systemically one would expect vasodilation to occur which in 
turn could affect blood pressure.  Indeed, in study I resting diastolic blood pressure was 
reduced by 3.7 mm Hg (p=<0.02) and mean blood pressure was reduced by 3.2 mm Hg 
(p=0.03) after a three-day intervention with sodium nitrate (0.1 mmol kg-1 day-1). Part of 
these data origins from study II. In study III we did not see any difference in resting blood 
pressures, (systolic 109 ± 5, diastolic 70 ± 2 mm Hg and systolic 109 ± 3, diastolic 
69 ± 2 mm Hg in the placebo and nitrate group, respectively). However, in the period 
immediately after exercise the diastolic blood pressure decreased from 69 ± 2 to 62 ± 3 mm 
Hg in the nitrate group (p=<0.05), an effect that was not observed in the placebo group. 
The discrepancy in results between study I and II vs study III is unknown but nitrate 
administration was three days in study I and II but only two days in study III. Also, 
measurement of resting blood pressure was done only 45 minutes after the last nitrate dose 
in study III (one hour in study I and II) which in subsequent studies turned out not to be 
enough for the maximum conversion of nitrate to nitrite [23]. In study IV blood pressure 
was measured by telemetry in rats that received nitrate (0.1 mmol kg−1 d−1) in the drinking 
water for 8 weeks. Mean arterial blood pressure measured over 72 hours was 
approximately 3 ±mm Hg lower in rats receiving nitrate compared to placebo (p<0.05). 
When rats were given L-NAME (1 g L-1) in the drinking water, blood pressure increased 
significantly in both groups but still remained lower in the nitrate group. For unknown 
reasons this increase was delayed by 12 hours in the nitrate group.  
 
Treatment of eNOS deficient mice with dietary nitrate  
As they age, eNOS-/- mice develop insulin resistance, high blood pressure, elevated 
triglyceride levels and visceral fat accumulation, features also present in the human 
metabolic syndrome. When these mice were fed nitrate chronically in the drinking water, 
the disturbed glucose homeostasis was essentially reversed (see Figure 2). Chronic feeding 
with nitrate was associated with elevated levels of nitros(yl)ation products (RXNO) 
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including S-nitrosothiols. In parallel, nitrate fed mice had a reduction in body weight, 
visceral fat and circulating triglycerides whereas the control mice had unchanged body 
weight. Surprisingly, there were no differences in food intake between groups indicating 
that the weight loss in the nitrate group was explained by increased activity or changes in 
metabolic rate compared to the control group.  
 
 
Figure 2 
 
 
Figure 2) Dietary nitrate improves glucose tolerance and reduces fasting blood glucose in 
eNOS-deficient mice. (A) Effects on glucose tolerance after 10 weeks of dietary sodium 
nitrate supplementation (0.1 mmol kg
−1
d
−1
) following i.p. injection of glucose (2 g kg
−1
) in 
controls (n = 11) and nitrate treated (n = 13) mice. (B) Effects on fasting glucose. (C) 
Effects on glycosylated hemoglobin (HbA1c) in nitrate treated (n = 8) and control mice (n 
= 10). (D) Effects on proinsulin-insulin ratios. Data are from the same animals as in B, but 
plasma was collected at the termination of the experiment after fasting for 14 h. Values 
are mean ± S.E.M. 
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Effects of inorganic nitrate on metabolism during exercise 
Considering the known role of NO in regulation of energetics we wanted to explore the 
effects of dietary nitrate during controlled physical exercise. It was plausible that nitrate 
supplementation fuelling the nitrate-nitrite-NO pathway, could have metabolic and 
circulatory effects.  
In study II oxygen consumption at all submaximal cycle ergometer workloads (45-85% of 
VO2max) was reduced by on average 160 ml min
-1 (p=0.02) after nitrate supplementation.  
VO2max was not significantly different between conditions (4.61 ± 0.28 L min
−1 after 
placebo and 4.49 ± 0.44 after nitrate, p = 0.29). However, maximal exercise testing during 
cycle ergometer exercise can be difficult in some individuals since VO2max often is higher 
during uphill running or combined arm and leg exercise [109]. In study III we therefore 
investigated the effect of nitrate on VO2max during maximal combined arm and leg 
exercise. During this type of exercise we found that VO2max was reduced from 3.72 ± 0.33 
to 3.62 ± 0.31 L min-1 in the placebo and nitrate conditions respectively (p=<0.05). Very 
surprisingly, the reduction in VO2max was accompanied by a trend towards an increase in 
time to exhaustion (524 ± 31 vs 563 ± 30 seconds, in placebo and nitrate respectively, 
p=0.13). In this study we could also show that acute administration of nitrate affected 
oxygen consumption during submaximal exercise. In study V we used a single low-
intensity workload and again we found that oxygen consumption was reduced from 1.95 ± 
0.09 L min−1 during the placebo trial to 1.89 ± 0.1 L min−1 after nitrate supplementation 
(p=0.02). In all studies heart rate and pulmonary ventilation was unaffected by dietary 
nitrate. In study II and III RER was unchanged but in study V we found a slight increase in 
RER from 0.883 ± 0.01 in the placebo trial to 0.914 ± 0.01 in the nitrate trial, (p=0.02). 
This increase in RER indicating more carbohydrate oxidation could not fully explain the 
reduction in VO2. In study II and III we measured capillary lactate concentrations before, 
during and after exercise at various workloads but found no significant differences.  
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Effects of dietary nitrate on basal mitochondrial function 
With more than 90% of total oxygen consumption being of mitochondrial origin [98] we 
hypothesized that the reduction in oxygen consumption was due to mitochondrial 
alterations after nitrate ingestion. In study V we obtained muscle biopsies from Vastus 
Lateralis from healthy volunteers after three days of nitrate or placebo supplementation as 
previously described. Mitochondria were isolated and a variety of respiratory parameters 
were studies. Mitochondrial state 3 respiration with pyruvate and malate as substrates was 
unaffected by nitrate supplementation (see Figure 3). Likewise, when respiration was 
uncoupled by the ionophore FCCP, respiration increased compared to state 3 but were not 
different between conditions. However state 4 respiration, both in the presence and absence 
of atractyloside, was significantly lower after nitrate supplementation. Also LEAK-
respiration, which is defined as the respiratory rate in the presence of substrates but without 
ADP, was significantly lower after nitrate. In study V we found q-values in the placebo 
condition of 0.966 that increased after nitrate supplementation to 0.985 (p=0.01, see Figure 
3). As a consequence of the lower state 4 respiration, RCR values increased from 6.5 ± 0.7 
to 8.5 ± 0.7 after nitrate, (p=0.006). 
 
  
 31 
 
Figure 3 
 
 
 
Figure 3) After three days of nitrate supplementation or placebo, skeletal muscle 
mitochondrial function was analyzed. (A) LEAK respiration (n = 9), (B) state 4 
respiration (n = 14), and (C) state 4 respiration with atractyloside (n = 6) were lower after 
dietary nitrate compared to with placebo. (D) Nitrate supplementation did not influence 
oxygen consumption during state 3 respiration (n = 14) or (E) uncoupled respiration 
achieved by optimal titration with FCCP (n = 6). (F) Thermodynamic coupling (q value), 
was improved by dietary nitrate compared to placebo (n = 6). Data are mean ± S.E.M. 
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 Effects of dietary nitrate on mitochondrial P/O ratio and oxygen affinity 
A common criticism against studies with isolated mitochondria is that they do not reflect 
the true physiological state in vivo. Indeed, mitochondrial assays most often contain 
saturating concentrations of substrates and ADP and are performed under air saturated 
oxygen levels [58]. In two sets of experiments we tried to better mimic the physiological 
conditions in muscle tissue. In both these experiments pH was set to 6.7, resembling the 
intracellular pH during exercise [110].  We first measured the P/O ratio at non-saturating 
ADP concentrations similar to those during exercise [111]. After three days of nitrate 
supplementation the P/O ratio was improved from 1.36 ± 0.06 in the placebo trials to 1.62 
± 0.07 (p=0.02, see Figure 4a) after nitrate administration, indicating an improved 
mitochondrial efficiency. This increase in mitochondrial P/O ratio was strongly associated 
with the reduction in whole-body oxygen consumption in the same individuals, see Figure 
4b.  
 
 
 
Figure 4 
 
 
Figure 4) (A) Mitochondrial P/O ratio measured under steady-state infusion of non-
saturating ADP-levels was improved after three days of nitrate supplementation. Values 
are mean ± S.E.M. (B) The increase in mitochondrial P/O ratio was significantly 
correlated with the decrease in whole-body oxygen consumption (R
2
=0.64, p=0.02).  
 
To study mitochondrial respiration at low oxygen tension, we measured the p50mito at state 
3 respiration in response to nitrate supplementation. In the placebo condition p50mito was 
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0.042 ± 0.002 kPa and was near significantly increased to 0.053 ± 0.002 kPa (p=0.09). 
Interestingly, when nitrite was added in vitro, p50mito increased in a dose-dependent manner 
(see Figure 5). 
 
Figure 5 
 
Figure 5) Mitochondrial oxygen affinity (p50mito) was measured in skeletal muscle 
mitochondria after placebo treatment. When nitrite was added in vitro, p50mito increased 
in a dose dependent manner. When pH in the respiration medium was increased from 6.7 
to 7.2 the effect was abolished. The effect of adding nitrite in vitro was compared to the 
effect after nitrate supplementation in vivo (black bar) that just failed to reach statistical 
significance (p=0.09). Values are mean ± S.E.M. 
 
Effects of dietary nitrate on expression of putative uncoupling proteins 
The reduced oxygen cost during exercise and the increased mitochondrial P/O ratio indicate 
that oxidative phosphorylation uncoupling is reduced after nitrate supplementation. Thus, 
we investigated the protein expression of two mitochondrial proteins, ANT and UCP-3, 
which have been proposed to uncouple respiration by allowing direct leakage of protons or 
by other means consuming the membrane potential [95, 112]. In study V we investigated 
the mitochondrial expression of these proteins by Western blotting and found that ANT 
was significantly reduced after nitrate supplementation (p=0.009). The reduction in UCP-3 
expression failed to reach statistical significance (p=0.17) due to one outlier (see Figure 6). 
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Figure 6 
 
 
Figure 6) Total protein expression of (A) UCP-3 and (B) ANT, measured with Western 
blotting, after three days of placebo and nitrate supplementation. 
 
Effect of dietary nitrate on mitochondrial biogenesis 
In study V a series of experiments were performed to examine if the decreased expression 
of ANT and possibly UCP-3 represented a selective down regulation of these proteins or if 
overall mitochondrial biogenesis and density were lower after nitrate. First, we measured 
the activity of CS and COX since they are often used as markers of mitochondrial density. 
There was no evidence of a change in the activity of these two enzymes after nitrate 
supplementation (see Figure 7). The amount of mitochondrial DNA and nuclear DNA in 
the tissue samples were quantified using rt-PCR. The ratio (mtDNA/nDNA) is considered a 
hallmark of mitochondrial density. As can be seen in Figure 7, there was no difference in 
the mtDNA/nDNA ratio. Furthermore, the mRNA levels of three genes involved in 
mitochondrial biogenesis and function were investigated; peroxisome proliferator-activated 
receptor gamma coactivator 1 alpha (PGC-1a), Transciption factor Alpha, mitochondrial 
(TFAM) and COX. Again, no differences were found in the gene expression between any 
of these genes (see Figure 7). 
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Figure 7 
 
 
Figure 7) Dietary nitrate does not induce changes in mitochondrial density or biogenesis. 
(A) Citrate synthase activity, (B) mtDNA/nDNA ratio, (C) mRNA-levels of PGC-1α, 
TFAM and COX IV and (D) Cytochrome c oxidase activity were not affected by three 
days of supplementation with dietary nitrate. Values are mean ± S.E.M. 
 
 Mitochondrial oxygen affinity predicts basal metabolic rate 
As explained above, metabolic efficiency or the efficiency of energy conversion is largely 
dictated by peripheral factors, the VO2max on the other hand, is mainly limited by the 
maximal oxygen delivery capacity, which in turn is dictated by the pumping capacity of the 
heart [113]. Interestingly, VO2max is readily increased by endurance training whereas 
efficiency during cycle ergometer exercise seems to be unaffected by such interventions 
[52, 114]. The finding that dietary nitrate seem to reduce both submaximal and maximal 
oxygen consumption indicates that there are more than one mechanism involved or that 
there is a link between metabolic efficiency and VO2max. In study VI it was investigated if 
there were any qualitative mitochondrial differences between subjects with widely different 
BMR and metabolic efficiency. A strong correlation between BMR and the subjects’ 
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p50mito (R
2=0.66, p=0.0004, see Figure 8) was found. A somewhat weaker relationship was 
found between cycling efficiency and p50mito (R
2=0.46, p=0.007). This indicates that there 
is a tight association between metabolic efficiency and the mitochondrial affinity for 
oxygen which theoretically could have an impact on the mitochondrial ability to extract 
oxygen when the oxygen availability is limiting such as during exercise [115].  
 
 
 
 
Figure 8 
 
Figure 8) Association between basal metabolic rate, expressed per kg body mass, and the 
oxygen tension where mitochondrial respiration rate is half maximal (p50mito). 
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GENERAL DISCUSSION 
 
When the first studies in this thesis were initiated, the knowledge about the metabolic and 
circulatory effects of dietary nitrate was very limited. In 1994 two independent groups had 
shown that salivary nitrate, after reduction to nitrite by bacteria in the oral cavity, could 
generate NO in the human acidic stomach [21-22]. A role for gastric NO in host defence 
and gastric mucosal homeostasis was suggested. The year after Zweier and colleagues 
found endogenous NO generation from nitrite in the ischemic heart but related this 
production to myocardial injury and loss of contractile function [116].  In 2001 it was 
demonstrated that physiological amounts of nitrite could vasodilate aortic strips in vitro, an 
effect that was potentiated as pH in the medium decreased to levels seen in hypoxic or 
ischemic tissues. Vasodilation was paralleled by NO generation and abolished in the 
presence of a sGC-inhibitor, indicating that NO was the active substance [117]. In 2003 
Gladwins’ group went on and found that nitrite at near-physiological doses vasodilated the 
human circulation [30]. Then in 2004 Webb and colleagues demonstrated NO-dependent 
cardioprotective effects of nitrite in ischemia-reperfusion injury [118], a finding that now 
has been confirmed in a large number of studies, for review see [119]. In spite of these 
findings NO researchers still considered nitrate to be metabolically inert and it was actually 
used as a supposedly ineffective control substance in many experiments.   In 2004 
Lundberg and Govoni showed that ingestion of dietary nitrate increased plasma levels of 
nitrite, a pathway dependent on nitrate reducing bacteria in the oral cavity [19]. With these 
studies as a background, it was hypothesized that intake of dietary nitrate would fuel a 
nitrate-nitrite-NO pathway, generating NO and other bioactive nitrogen intermediates that 
could exert important biological effects. 
 
 
Dietary nitrate and blood pressure 
The results in study I, II and partly in III show that ingestion of dietary nitrate decreases 
blood pressure, an effect likely mediated by formation of NO. Blood pressure was also 
reduced after chronic dietary nitrate supplementation in rats in paper IV.  The effect on 
blood pressure in humans has later been confirmed both with nitrate salts and beetroot juice 
as a natural source of nitrate [23, 108, 120-124]. Together these studies show both acute 
(single dose) and chronic blood pressure lowering effects. The latter suggests that there is 
no development of tolerance during nitrate intake in contrast to what is found with organic 
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nitrates [125]. Interestingly, Webb et al. and Petersson et al. found that when the 
enterosalivary circulation of nitrate and reduction to nitrite in the oral cavity was disrupted, 
either by spitting or the use of an antibacterial mouthwash, both the increase in plasma 
nitrite and decrease in blood pressure were abolished [23, 124]. This clearly shows that the 
reduction of nitrate to nitrite by oral commensal bacteria is a crucial first step in the 
bioconversion of nitrate to NO. The exact mechanism behind the blood pressure lowering 
effect is not fully elucidated. No nitrate-induced increase in plasma cGMP could be 
detected to support NO-mediated vasodilation but this has been described by Kapil et al. 
after ingestion of beetroot juice [108]. Although the most probable cause is vasodilation, 
cardiac and renal effects cannot be completely ruled out at this stage. Nitrite has been 
shown to have a negative inotropic effect in animal ex vivo studies [126].  
Since vegetables contain high amounts of inorganic nitrate our findings clearly need to be 
put in a nutritional perspective. As of today nitrate is considered a potentially harmful and 
therefore undesired constituent in our diet and drinking water, in need of strict regulation. 
One the other hand there is consensus that a diet rich in vegetables promotes health. In fact 
such diets have been used in a controlled fashion to lower blood pressure (Dietary 
Approaches to Stop Hypertension, DASH) [51].  In these studies the blood pressure 
lowering effect was very similar to what was observed in our studies with inorganic nitrate. 
Other studies aiming at pinpointing the active components underlying the salutary effects 
of vegetables have not been successful.  In a recent study Lansley and co-workers used a 
nitrate-depleted beetroot juice as placebo and found that this juice lacked the blood pressure 
lowering effects found with the natural juice [127]. Together, these data suggest the 
intriguing possibility that inorganic nitrate is an active ingredient in vegetables and may 
underlie their beneficial cardiovascular effects. Other salubrious effects of nitrate such as 
inhibition of platelet aggregation, improvement in endothelial function and protection 
against ischemia-reperfusion injury further support its role as a potentially beneficial 
component of a “green diet” [23].  
 
Dietary nitrate and exercise 
In the nitrate-nitrite-NO pathway the reduction of nitrite to NO and other nitrogen oxides is 
markedly enhanced during hypoxic and acidic conditions. In addition, NO is known to be 
involved in vasoregulation and modulation of cellular respiration, two important parts of 
the acute adaptation to exercise.  Since both intracellular oxygen tension and pH is low in 
the working muscle during exercise it was plausible that dietary nitrate would have effects. 
Using human subjects and modern exercise physiology laboratory equipment, biopsies 
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were obtained in a cross-over fashion and steady-state metabolism was studied during 
highly standardized conditions, using methods with known good reproducibility. 
The results from study II, III and V demonstrate that oxygen consumption is decreased 
after nitrate supplementation both at submaximal and maximal workloads. This is achieved 
without increases in plasma lactate indicating improved aerobic efficiency. In study V it 
was found that the reduction in oxygen consumption was coupled to an increased 
mitochondrial efficiency with improved P/O ratio, lower LEAK-respiration, lower state 4 
respiration and a reduction in protein expression of ANT and possibly UCP-3.  The 
increased P/O ratio correlated with the reduction in oxygen cost during exercise which 
strongly suggests that the observed improvement in mitochondrial efficiency is related to 
the oxygen sparing effects during exercise. The reduced oxygen consumption after nitrate 
supplementation seems to be a consistent finding during submaximal exercise [120-122, 
128-131]. At maximal exercise the reduction is slightly more inconsistent with some 
studies showing decreased [121, 132-133] but others unchanged VO2max [130-131]. The 
discrepancy between these results is not clear but the mode of exercise, dose and timing of 
nitrate supplementation and subject characteristics may all contribute to the divergent 
results. The exact mechanism how nitrate can reduce VO2max is still unclear.  The Fick 
equation states that: 
VO2max = Q (CaO2-CvO2) 
where Q denotes cardiac output, CaO2 is the oxygen content in arterial blood and CvO2 is 
the oxygen content in venous blood. There are no indications of changes in Q has after 
nitrate supplementation, since maximal heart rate is unaffected. Further, the a-vO2 
difference is lower during exercise after nitrate supplementation [120]. This implies that the 
effect of nitrate lies primarily in the periphery with no substantial effect on cardiac output.  
 
Does dietary nitrate improve physical performance? 
An intriguing observation is that although several studies now show a decreased VO2max 
by dietary nitrate, performance seems to improve [90-92, 97, 101]  (see Table 4 for more 
details about performance during exercise).  This is highly surprising since other known 
interventions that decrease VO2max also decrease work performance accordingly. 
Examples of such interventions are hypoxic exposure [134], treatment with β-adreno 
receptor antagonists  [135] and induced anemia [136]. The underlying mechanism for these 
two apparently paradoxical effects is unknown. In study VI a novel hypothesis is presented 
where p50mito is the common characteristic that unifies metabolic efficiency at rest and 
during submaximal exercise with VO2max.  
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An increased efficiency during submaximal work should theoretically be beneficial for 
endurance performance since the same amount of work can be accomplished using less 
energy. Indeed, Horowitz et al. found that performance was different between two groups 
of cyclists with matched VO2max but with significantly different gross efficiencies (20.4 vs 
21.9%). During a one hour simulated time-trial the most efficient group of cyclists had an 
almost 10% higher average power output than the less efficient group [137]. In study II 
gross efficiency was increased from 19.7 to 21.1% after nitrate supplementation which 
theoretically could indicate an improved performance level. All studies summarized in 
Table 4 use time to exhaustion either at a fixed workload or during incremental exercise as 
measure of performance. A recent study by Lansley et al [127] instead used a time-trial 
design where competitive cyclists were instructed to cover a set distance at the fastest 
possible time, similar to a “real” athletic event. After nitrate supplementation, time to finish 
the distance was significantly reduced from 27.7 minutes to 26.9 minutes, indicating a 
substantially improved performance capacity. Future studies will reveal if dietary nitrate 
affect also other factors related to physical performance such as stimulation of the central 
nervous system, fatigue mechanisms, intracellular calcium levels etc. 
 
Table 4) Effects of acute or chronic supplementation with nitrate either as a sodium 
nitrate or with nitrate rich beetroot juice (BR) on time to exhaustion during exercise.  
Study Subjects Mode of nitrate 
administration 
Work 
mode 
Work 
time 
(min) 
nitrate 
Work 
time  
(min) 
placebo 
Time 
difference 
Statistics 
[131] Young, 
healthy 
BR, 6 days Cycling 11:15 9:43 15.8% p<0.05 
[133] Young, 
healthy 
Sodium nitrate, 
2 days 
Arm and 
leg cycl. 
9:23 8:44 7.5% p=0.13 
[132] Cyclists, 
triathletes 
Sodium nitrate, 
acute dose 
Cycling 6:56 6:49 1.7% p=0.17 
[120] PAD BR, acute dose Walking 8:53 7:47 17% p<0.05 
[129] Young, 
healthy 
BR, 6 days Knee-
extension 
12:14 9:46 25%  
p<0.01 
[121]               Young, 
healthy 
BR, 6 days Running      8:42 7:36 15%                    p<0.01 
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NO formation from dietary nitrate. 
Although NO gas is readily detectable in vitro by laboratory techniques such as 
chemiluminescence, its detection in vivo is by no means straightforward. Instead of 
measuring NO directly, a variety of biomarkers or bioassays can be used as evidence of NO 
like activity, including cGMP-formation and citrulline to arginine ratio. In addition, 
measurable NO-like effects include proliferation of endothelial cells [138], stabilization of 
HIF-1 [139], the inhibition of COX  [4] induction of nitrosative stress. The strongest 
evidence of NO-formation in the present thesis is the reduction in blood pressure that 
indicates peripheral vasodilation and the reduced oxygen consumption during exercise that 
might be interpreted as COX inhibition of NO or its chronic manifestations [140]. In 
addition, the fact that nitrate could partly reverse metabolic disturbances associated with the 
lack of eNOS, also indicates formation of NO or NO-like bioactivity. 
 
An hypothesis how COX redox state controls metabolic efficiency, 
initiates cell signaling events and is shifted by dietary nitrate 
As a last section in this thesis I would like to speculate on the temporal events and signaling 
pathways involved in the regulation of metabolism following nitrate intake. There seems to 
be both acute [127, 132-133] and chronic [120-121, 130-131, 141] effects on metabolism 
following nitrate administration. The acute effect, occurring within 1-3 hours after nitrate 
intake, could be related to nitrate being reduced to nitrite that is taken up by the tissue 
[142]. When the intracellular milieu is appropriate, as during exercise, nitrite is reduced to 
NO which subsequently inhibits COX.  When NO binds to COX the enzyme is more 
reduced and slippage in the proton and/or electron transfer is attenuated [143], thereby 
improving the oxidative phosphorylation coupling and the whole-body efficiency, 
especially under conditions of limited oxygen availability. Simultaneously, the lower 
turnover of COX in the presence of NO increases the p50mito and thereby reduces the 
mitochondrial capacity to bind to and extract oxygen under normal physiological 
conditions. During severe intensity exercise the increased p50mito reduces VO2max even 
though the oxygen transport from the heart is unaltered. However, the gain in efficiency is 
larger than the decrement in VO2max so work performance is maintained or even 
increased. A potential outcome of sustained COX-inhibition by NO and a reduced ETS is 
that generation of radical species can be increased [84, 144]. Reaction products of 
superoxide, in particular H2O2 and ONOO
-, can initiate important signaling events involved 
in the cellular stress response. Such reactions might possibly explain the nitrate induced  
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structural modifications of proteins and down regulation of uncoupling proteins such as 
ANT and UCP-3 (study V) and irreversible inhibition of COX  [140].  
 
An interesting observation is that the physiological and mitochondrial adaptations after 
nitrate supplementation are similar to those expected after acute or chronic hypoxic 
exposure. For instance, although controversial, several studies show reduced oxygen 
consumption at a fixed workload after weeks of hypoxic exposure when measured at sea 
level [145-148]. Further, populations adapted for several generations to altitude seem to 
be metabolically more efficient, which is true both for Andeans [149] and for Tibetans 
[150]. Interestingly, another study shows that Tibetans have better metabolic efficiency 
and much higher exercise performance but lower VO2max than a matched population 
residing at lower altitudes [151]. This could be indicative of chronic exposure to elevated 
NO-levels and a high p50mito as explained above. Indeed, a recent study also found that 
Tibetans have more than ten-fold higher circulating levels of nitrate and nitrite compared 
to sea-level residents, likely reflecting an upregulation of NOS activity [152]. 
 
To summarize, in this thesis we present novel biological functions of the mammalian 
nitrate-nitrite-NO pathway. By fuelling this pathway with dietary intake of inorganic 
nitrate we can achieve effects on blood pressure, mitochondrial function and oxygen 
utilization during exercise.  In addition, nitrate supplementation reverses features of the 
metabolic syndrome in eNOS deficient mice. However, the true physiological role of 
the nitrate-nitrite-NO pathway in relation to the canonical NO-synthases still remains to 
be elucidated. Nevertheless, these findings implicate a therapeutic potential of nitrate as 
well as a nutritional role of this anion.   
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CONCLUSIONS 
 
 Dietary nitrate has a mild blood pressure lowering effect when administered to 
humans and rodents. 
 Many features of the metabolic syndrome in eNOS-deficient mice are attenuated 
after long-term treatment with nitrate in the drinking water. 
 Whole-body oxygen uptake during submaximal as well as maximal exercise is 
reduced after nitrate administration. This occurs with unchanged or even 
improved physical performance. 
 Mitochondrial efficiency improves after nitrate supplementation; this effect is 
directly correlated with the reduction in whole-body oxygen consumption. 
 The improvement in mitochondrial efficiency is paralleled by a reduced 
expression of ANT, an important mitochondrial protein that has the potential to 
uncouple mitochondrial respiration. 
 The p50mito can have important regulatory effects and is correlated to metabolic 
efficiency.  
 Long term effects of nitrate administration has not been investigated but the 
traditional view that nitrate intake should be reduced to the lowest possible level 
is now seriously challenged. 
  The benefits of short-term nitrate administration indicate that the relationship 
between nitrate-reducing bacteria in the oral cavity and the host mammal should 
be revised from “commensal” where only the bacteria  benefits from the 
relationship and the host is unharmed, to “symbiotic” since both bacteria and the 
host seem to benefit from their relationship.  
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